Volume 28, Number 2—February 2022
CME ACTIVITY - Synopsis
Clinical and Laboratory Characteristics and Outcome of Illness Caused by Tick-Borne Encephalitis Virus without Central Nervous System Involvement
Table 1
Characteristic | Value |
---|---|
Sex | |
F | 51 (52.0, 41.7–62.2) |
M |
47 (48.0, 37.8–58.3) |
Median age, y (IQR) |
51 (37–60.75) |
Underlying illnesses |
38 (38.8, 29.1–49.2) |
History of tick bite† |
86 (88.7, 80.6–94.2) |
Median incubation period, d (IQR)‡ |
6 (4–9.75) |
Median duration of illness before first evaluation, d (IQR) |
5 (4–6) |
Clinical manifestation | |
Body temperature >37.5°C | 95 (96.9, 91.3–99.4) |
Median body temperature, °C (IQR)§ | 38.3 (37.8–38.9) |
Chills | 19 (19.4, 12.1–28.6) |
Headache | 84 (85.7, 77.2–92.0) |
Myalgia | 53 (54.1, 43.7–64.2) |
Arthralgia | 42 (42.9, 32.9–53.3) |
Gastrointestinal symptoms | 45 (45.9, 35.8–56.3) |
Abdominal pain | 2 (2.0, 0.3–7.2) |
Nausea, vomiting | 37 (37.8, 28.2–48.1) |
Diarrhea | 16 (16.3, 9.6–25.2) |
Malaise and fatigue | 96 (98.0, 92.8–99.8) |
Respiratory symptoms | 18 (18.4, 11.3–27.5) |
Sore throat | 11 (11.2, 5.7–19.2) |
Cough |
10 (10.2, 5.0–18.0) |
Median duration of illness, initial phase, d (IQR)¶ |
7 (6–8) |
Hospitalization | |
No. hospitalized patients | 37 (37.8, 28.2–48.1) |
Median duration of hospitalization, d (IQR)# | 3 (1–5) |
*Values are no. (%, 95% CI) except as indicated. IQR, interquartile range. †Tick bite within 4 weeks before onset of illness. Data available for 97 patients. ‡Time (days) from tick bite to onset of illness calculated only in patients with 1 bite. Data available for 54 patients. §Highest temperature in the course of the illness. ¶Data available for 82 patients. #Data available for 33 patients.
Page created: December 02, 2021
Page updated: January 21, 2022
Page reviewed: January 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.